12. Clinical characteristics in Parkinson patients having hypertension

Tran Viet Luc, Nguyen Ngoc Tam, Hoang Ngoc Dung

Main Article Content

Abstract

This purpose of this cross-sectional study on 50 Parkinson patients is to describe the clinical characteristics of Parkinson patients with hypertension. The mean age of the study group was 69.38 ± 7.99. The rates of Parkinson's patients with grade 1 and grade 2 hypertension are 44% and 56%, respectively. late-onset Parkinson's patients often had typical forms (87.5%), tremors (12.5%), but no patient has hypertonic/immobilization, while there were 2 patients in the hypertonic/immobilization form in the early-onset group. Sleep disturbance was significantly more common in the Parkinson's group with hypertension and late onset. There are 2 motor complications encountered in our study group: movement fluctuations and dyskinesias. 25% of patients had orthostatic hypotension, but there was no difference between the 2 groups according to the degree of hypertension. The maximum, minimum, and average blood pressure in late-onset Parkinson's disease group were significantly higher than those in early-onset group, with statistical significance with p < 0.05. Clinical symptoms of Parkinson patients with hypertension differ between early and late onset groups. We suggest that additional researches are needed to study in depth on the treatment characteristics of this population.

Article Details

References

1. Tarakad A, Jankovic J. Diagnosis and Management of Parkinson’s Disease. Semin Neurol. 2017; 37(02): 118-126. doi:10.1055/s-0037-1601888.
2. Unger T, Borghi C, Charchar F, et al. International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75(6): 1334-1357. doi:10.1161/HYPERTENSIONAHA.120.15026.
3. Wang X, Zeng F, Jin WS, et al. Comorbidity burden of patients with Parkinson’s disease and Parkinsonism between 2003 and 2012: A multicentre, nationwide, retrospective study in China. Sci Rep. 2017; 7:1671. doi:10.1038/s41598-017-01795-0.
4. The global epidemiology of hypertension - PMC. Accessed October 2, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998524/.
5. Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, et al. Neuropsychiatric symptoms and caregiver’s burden in Parkinson’s disease. Parkinsonism Relat Disord. 2015; 21(6): 629-634. doi:10.1016/j. parkreldis.2015.03.024.
6. Macchi ZA, Koljack CE, Miyasaki JM, et al. Patient and caregiver characteristics associated with caregiver burden in Parkinson’s disease: a palliative care approach. Ann Palliat Med. 2020; 9(Suppl 1): S24-S33. doi:10.21037/apm.2019.10.01.
7. Genç F, Yuksel B, Tokuc FEU. Caregiver Burden and Quality of Life in Early and Late Stages of Idiopathic Parkinson’s Disease. Psychiatry Investig. 2019; 16(4): 285-291. doi:10.30773/pi.2019.02.20.
8. de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson’s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry. 1996; 61(1): 70-74.
9. Asahina M, Vichayanrat E, Low DA, Iodice V, Mathias CJ. Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology. J Neurol Neurosurg Psychiatry (2013) 84(6): 674–80. 10.1136/jnnp-2012-303135.
10. Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008; 79(4): 368-376. doi:10.1136/jnnp. 2007. 131045.
11. Ferguson LW, Rajput AH, Rajput A. Early-onset vs. Late-onset Parkinson’s disease: A Clinical-pathological Study. Can J Neurol Sci J Can Sci Neurol. 2016; 43(1): 113-119. doi:10.1017/cjn.2015.244.
12. Yu QJ, Yu SY, Zuo LJ, et al. Parkinson disease with constipation: clinical features and relevant factors. Sci Rep. 2018; 8(1): 567. doi:10.1038/s41598-017-16790-8.
13. The impact of non-motor symptoms on the quality of life of Parkinson’s disease patients: a longitudinal study - PubMed. Accessed October 19, 2022. https://pubmed.ncbi.nlm.nih.gov/26806538.
14. Poewe W. Non-motor symptoms in Parkinson’s disease. Eur J Neurol. 2008; 15 Suppl 1:14-20. doi:10.1111/j.1468-1331.2008.02056.
15. Li L, Guo P, Ding D, et al. Parkinson’s disease with orthostatic hypotension: analyses of clinical characteristics and influencing factors. Neurol Res. 2019; 41(8): 734-741. doi:10.1080/01616412.2019.1610224.
16. Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A. Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology. 2017; 88(1): 17-24. doi:10.1212/WNL. 0000000 0000 03452.